US FDA grants EUA for Novavax COVID-19 vaccine, adjuvanted for adolescents aged 12 through 17 years
Novavax vaccine is the first protein-based COVID-19 vaccine authorised in the US
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
emergency use authorisation
Novavax expects to apply for full approval of COVID vaccine in H2
The company, late last month, filed for Emergency Use Authorisation (EUA) of the shot in US adults, a much-awaited step following…
Novavax submits final data to US FDA as prerequisite to EUA application request for COVID-19 vaccine
Novavax has filed the complete CMC data package, which leverages Novavax's manufacturing partnership with the Serum Institute of…
Evusheld long-acting antibody combination retains neutralising activity against Omicron variant in…
Only antibody authorised in the US for pre-exposure prophylaxis of COVID-19
Merck and Ridgeback seek Emergency Use Authorisation from US FDA for Molnupiravir
If authorised, Molnupiravir could be the first oral anti-viral medicine for the treatment of COVID-19
Bharat Biotech submits clinical trial data of Covaxin in children to CDSCO
As part of the phase-II/III trial, the two-dose Covaxin was administered with 28 days apart.
DCGI gives nod to Cadila Healthcare to conduct phase-III trials for two-dose COVID vaccine
The company has already received the Emergency Use Authorisation (EUA) from the Drug Controller General of India (DCGI) for…
WHO might give nod for Covaxin this month
The WHO has so far approved Covid vaccines developed by Pfizer-BioNTech, US pharma majors Johnson & Johnson, Moderna, China’s…
J&J single-dose COVID-19 vaccine gets approval for EUA in India
The single-shot vaccine in clinical trials proved to be 85 per cent effective in preventing COVID-19
Covaxin receives GMP certificate from Hungarian authorities
Covaxin has received a certificate of Good Manufacturing Practice (GMP) compliance from the Hungarian authorities, Bharat Biotech…